The Safety of Pharmacotherapy for IBS: Limitations

The Safety of Pharmacotherapy for IBS: Key Takeaways

The Safety of Pharmacotherapy for IBS: Individualizing Therapy

The Safety of Pharmacotherapy for IBS: Symptom Flip

The Safety of Pharmacotherapy for IBS: Tricyclic Antidepressants

The Safety of Pharmacotherapy for IBS: IBS-D Results

The Safety of Pharmacotherapy for IBS: IBS-C Results

The Safety of Pharmacotherapy for IBS: Primary Results

The Safety of Pharmacotherapy for IBS: NNH

The Safety of Pharmacotherapy for IBS: Overview

Carbohydrate Intolerance Study: Clinical Implications

Phase 3 BREAKWATER Study: Clinical Implications

Carbohydrate Intolerance Study: Proposed Mechanisms

Carbohydrate Intolerance Study: Predictors of Intolerance

Phase 3 BREAKWATER Study: Safety Profile

Phase 3 BREAKWATER Study: Subgroup Analysis

Carbohydrate Intolerance Study: Fructose Intolerance Symptom Patterns

Phase 3 BREAKWATER Study: Overall Survival

Phase 3 BREAKWATER Study: Duration of Response

Carbohydrate Intolerance Study: Lactose Intolerance Symptom Patterns

Phase 3 BREAKWATER Study: Objective Response Rate

Carbohydrate Intolerance Study: Prevalence of Intolerance

Phase 3 BREAKWATER Study: Population Characteristics

Carbohydrate Intolerance Study: Patient Population

Phase 3 BREAKWATER Study: Trial Design & Endpoints

Carbohydrate Intolerance Study: Design & Methods

Carbohydrate Intolerance Study: Distinguishing Malabsorption, Maldigestion, & Intolerance

Phase 3 BREAKWATER Study: Mechanistic Rationale for Combination Therapy

Carbohydrate Intolerance Study: Overview

Phase 3 BREAKWATER Study: Overview

ASPREE Follow-Up: Clinical Takeaways

ASPREE Follow-Up: Colorectal Cancer

ASPREE Follow-Up: Mechanistic Hypotheses

ASPREE Follow-Up: Why This Trial Differs

ASPREE Follow-Up: Melanoma Outlier

IBS Behavioural Therapies: Key Takeaways

IBS Behavioural Therapies: Target Matters More Than Technique

IBS Behavioural Therapies: Quality of Review

ASPREE Follow-Up: Legacy Effect

IBS Behavioural Therapies: Digital Therapies

ASPREE Follow-Up: Signal by Cancer Stage

IBS Behavioural Therapies: Long-Term Efficacy Gaps

IBS Behavioural Therapies: Using Therapies Earlier

ASPREE Follow-Up: Effects of Aspirin in Risk of Cancer

IBS Behavioural Therapies: Gut Pain Regulation

ASPREE Follow-Up: Cancer Incidence Outcomes

ASPREE Follow-Up: Study Overview

IBS Behavioural Therapies: Hypnotherapy & CBT Evidence

IBS Behavioural Therapies: Minimal Contact Disease Self Management

IBS Behavioural Therapies: Overview & Methods

COMMIT_10

COMMIT_9

COMMIT_8

COMMIT_7

COMMIT_6

COMMIT_5

COMMIT_4

COMMIT_3

COMMIT_2

COMMIT_1